Revolution for dogs and cats is an easy to use topical treatment that kills fleas flea eggs ear mites scabies and controls dog tick infestations in dogs In addition it helps with heartworm control as well as the spread of parasitic worms like roundworm and hookworm This monthly solution for tick and flea prevention in dogs and cats is FDAapproved and safe to use Applied to the base of your pets neck Revolution is a quick drying nongreasy medication that seeps into the pets skin to more efficiently distribute the medicine all across your pets body
Never before have two revolutions with so much potential to save and prolong human life occurred simultaneously. The converging, synergistic power of the biochemical and digital revolutions now allows us to read every letter of life's code, create precisely targeted drugs to control it, and tailor their use to individual patients. Cancer, diabetes, Alzheimer's and countless other killers can be vanquishedif we make full use of the tools of modern drug design and allow doctors the use of modern data gathering and analytical tools when prescribing drugs to their patients. But Washington stands in the way, clinging to outdated drug-approval protocols developed decades ago during medicine's long battle with the infectious epidemics of the past. Peter Huber, an expert in science, technology, and public policy, demonstrates why Washington's one-size-fits-all drug policies can't deal with diseases rooted in the complex molecular diversity of human bodies. Washington is ill-equipped to handle the torrents of data that now propel the advance of molecular medicine and is reluctant to embrace the statistical methods of the digital age that can. Obsolete economic policies, often rationalized as cost-saving measures, stifle innovation and suppress investment in the medicine that can provide the best cures at the lowest cost. In the 1980s, an AIDS diagnosis was a death sentence, until the FDA loosened its throttling grip and began streamlining and accelerating approval of life-saving drugs. The Cure in the Code shows patients, doctors, investors, and policy makers what we must now do to capture the full life-saving and cost-saving potential of the revolution in molecular medicine. America has to choose. At stake for America is the power to lead the world in mastering the most free, fecund, competitive, dynamic, and intelligent natural resource on the planetthe molecular code that spawns human life and controls our health.
With a Foreword by Geoffrey Nowell-Smith From Hollywood blockbusters to artists' film and video, distributors play a vitally important role in getting films in front of audiences. As the link between production and exhibition, their acquisition policies, promotional practices, and level of resources determine what is available, and so help shape the very nature of our film culture. Reaching Audiences is centrally concerned with the distribution practices that have been developed to counter Hollywood's traditional dominance of the marketplace, and ensure audiences have access to a more diverse moving image culture. Through a series of case studies, the book tracks the inventive distribution and exhibition initiatives developed over the last 40 years by an array of small companies on the periphery of the beleaguered UK film industry. That their practices are now being replicated by a new generation of digital distributors demonstrates that, while the digital revolution' has rendered those practices far easier to undertake and hugely increased their scope, the key issues in securing a more diverse moving image culture are not technological. Although largely invisible to outsiders, the importance of distributors and distribution networks are widely recognized within the industry, and Reaching Audiences is a key contribution to our understanding of the role they both do and can play.
For more than half a century, marketers have bombarded customers with more and more choices in products and services. What is the result? Unprecedented anxiety. Our mental circuit breakers are on overload. In fact, pioneering brand strategists Steven M. Cristol and Peter Sealey assert that we have reached our manageable threshold for making decisions -- and a watershed in product proliferation. In this pathbreaking book, the authors argue with compelling evidence that the next generation of marketing successes will belong to those brands that simplify customers' lives or businesses in ways that are inextricably tied to brand and product positioning. They contend that if a brand is not reducing customer stress, it is creating it -- and it is vulnerable to losing market share to more customer-empathetic competitors. Writing especially for product or brand managers who are struggling to simplify their portfolios, Cristol and Sealey have created a breakthrough framework that is itself a lesson in simplicity. After presenting two essential guideposts for managers to assess where their brand sits on the stress spectrum, the authors turn to the heart of Simplicity Marketing -- the 4 R's of simplification: Replace, Repackage, Reposition, and Replenish. Using scores of real-world company examples, Cristol and Sealey show how each of the 4 R's interacts with the others in powerful ways to relieve customer stress and how these strategies may be executed individually or in combination to build brand loyalty. Here for the first time are ten specific strategies to relieve customer stress through consolidating, aggregating, or integrating products and services, repositioning brands for more relevance to stress reduction, and decluttering customers' decision-making requirements. The final pages of this brilliant manifesto for a simplicity revolution provide a guide to managing simplicity strategies, leveraging information technology to simplify rather than complicate customers' lives, and integrating all the tools in the book into an executional blueprint.